Direct CDKN2 Modulation of CDK4 Alters Target Engagement of CDK4 Inhibitor Drugs.
Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-18-0755
Full Text
Open PDFAbstract
Available in full text
Date
March 5, 2019
Authors
Publisher
American Association for Cancer Research (AACR)